Nasopharyngeal Cancer

Nasopharyngeal Cancer

Regular price
$30.00
Sale price
$30.00
Regular price
Sold out
Unit price
per 
Shipping calculated at checkout.

Anatomy of the pharynx; drawing shows the nasopharynx, oropharynx, and hypopharynx. Also shown are the nasal cavity, oral cavity, hyoid bone, larynx, esophagus, and trachea. In the United States, nasopharyngeal cancer is rare, with less than one case diagnosed for every 100,000 people each year. While the overall incidence is low, certain ethnic and geographic groups have a significantly higher risk.   

Latest nasopharyngeal cancer data

There were 120,434 new cases of nasopharyngeal cancer in 2022. The tables below give information about the countries with the highest rates, incidence and mortality from nasopharyngeal cancer.

Nasopharyngeal cancer age-standardised rates

Age-standardised rates (ASR) are a summary measure of the rate of disease that a population would have if it had a standard age structure. Standardisation is necessary when comparing populations that differ with respect to age because age has a powerful influence on the risk of developing/dying from cancer.

It is important to note that some countries have a high ASR but a low total number of cases, while other have a low ASR but a high number of cases. This is because ASRs are reported per 100,000 people. So, for example, an ASR of 10 in a population of 100,000 = 10 cases of cancer, but an ASR of 1 in a population of 10 million = 100 cases.

The following table gives the top 5 countries by ASR for nasopharyngeal cancer incidence for both sexes combined.

Country New cases 2022 ASR
Maldives 36 7.5
Brunei 32 6.4
Indonesia 18,835 6.1
Malaysia 2,144 5.9
Singapore 540 5.4

The following tables give the top 5 countries by ASR for nasopharyngeal cancer incidence for men and women in 2022.

Country New cases in men ASR
Maldives 29 10.8
Indonesia 14,497 9.6
Malaysia 1,634 8.9
Brunei 22 8.7
Singapore 417 8.0
Country New cases in women ASR
Brunei 10 4.0
Maldives 7 3.5
Indonesia 4,338 2.8
Malaysia 510 2.8
Laos 85 2.7

Nasopharyngeal cancer incidence (cases)

China, Indonesia and India had the highest number of nasopharyngeal cancer cases in 2022.

The following 3 tables show the 10 countries with the highest nasopharyngeal cancer incidence in 2022 – 1st for both sexes, then men and women separately. We have also included the ASRs for each of these countries.

Rank Country New cases ASR/100,000
World 120,434 1.3
1 China 51,010 2.4
2 Indonesia 18,385 6.1
3 India 6,519 0.5
4 Vietnam 5,613 4.7
5 Philippines 3,684 3.5
6 Thailand 2,350 2.2
7 Malaysia 2,144 5.9
8 Myanmar 2,097 3.5
9 US 2,008 0.4
10 Algeria 1,608 3.5
Rank Country New cases in men ASR/100,000
World 86,289 1.9
1 China 35.656 3.4
2 Indonesia 14,497 9.6
3 India 4,275 0.6
4 Vietnam 4,003 7.1
5 Philippines 2,539 5.2
6 Thailand 1,687 3.3
7 Malaysia 1,634 8.9
8 US 1,420 0.6
9 Myanmar 1,400 5.1
10 Algeria 1,109 4.8
Rank Country New cases in women ASR/100,000
World 34,145 0.7
1 China 14,354 1.3
2 Indonesia 4,338 2.8
3 India 2,244 0.3
4 Vietnam 1,610 2.5
5 Philippines 1,145 2.1
6 Myanmar 697 2.1
7 Thailand 663 1.2
8 US 588 0.2
9 Malaysia 510 2.8
10 Algeria 499 2.2

Nasopharyngeal cancer deaths

China, Indonesia and India had the highest number of deaths from nasopharyngeal cancer in 2022.

The following 3 tables show the 10 countries with the highest number of nasopharyngeal cancer deaths in 2022 – 1st for both sexes, then men and women separately. We have also included the ASRs for each of these countries.

Rank Country Number ASR/100,000
World 73,482 0.8
1 China 28,408 1.2
2 Indonesia 12,949 4.3
3 India 4,780 0.3
4 Vietnam 3,453 2.9
5 Philippines 2,306 2.3
6 Thailand 1,506 1.3
7 Malaysia 1,496 4.2
8 Myanmar 1,443 2.4
9 Nigeria 1,092 0.9
10 Algeria 971 2.2
Rank Country Number in men ASR/100,000
World 54,104 1.2
1 China 21,181 1.8
2 Indonesia 10,251 7.0
3 India 3,136 0.4
4 Vietnam 2,465 4.5
5 Philippines 1,690 3.7
6 Malaysia 1,174 6.5
7 Thailand 1,084 2.0
8 Myanmar 990 3.7
9 Nigeria 754 1.4
10 Algeria 682 3.1
Rank Country Number in women ASR/100,000
World 19,378 0.4
1 China 7,127 0.6
2 Indonesia 2,698 1.7
3 India 1,644 0.2
4 Vietnam 988 1.5
5 Philippines 616 1.1
6 Myanmar 453 1.4
7 Thailand 422 0.7
8 Nigeria 338 0.5
9 Malaysia 322 1.8
10 Algeria 289 1.3
 General Clinical Manifestations
  • Epistaxis, usually a small amount of Blood (initial stage)
  • Nasal obstruction (early stage)
  • Tumor in the nose
  • Tinnitus
  • Deafness
  • Masses of the neck
  • Vernet's syndrome
  • Platoplegia
  • Asymmetry of the palate
  • Disappearance of the mouth opening
  • Migraines
  • Dysphagia
  • Choking sensation while drinking
  • Hoarseness
  • Exophthalmos
  • Blindness
  • Usually asymptomatic at the early stage
  • The tumor may appear as a cauliflower-like nodule or ulceration on the nasopharynx or as membrane erosion of abnormal color
  • If the tumor infiltrates to the submucosal layer, the surface of the membrane will be smooth and the nasopharynx will be depressed
  • Cranial nerve involvement is reflected by:
    Paralysis of the eyeball
    Facial hypothesia or hypoalgesia
    Difficulty opening the mouth
    Inclination of the tongue when it protrudes
    Aphasia
    Paralysis of the soft palate
    Disappearance of the gullet response

Clinical Manifestations For Wind-Heat Attacking the Lungs
  • Epistaxis, usually a small amount of Blood (initial stage)
  • Nasal obstruction (early stage)
  • Tumor in the nose
  • Tinnitus
  • Deafness
  • Masses of the neck
  • Vernet's syndrome
  • Platoplegia
  • Asymmetry of the palate
  • Disappearance of the mouth opening
  • Migraines
  • Dysphagia
  • Choking sensation while drinking
  • Hoarseness
  • Exophthalmos
  • Blindness
  • Usually asymptomatic at the early stage
  • The tumor may appear as a cauliflower-like nodule or ulceration on the nasopharynx or as membrane erosion of abnormal color
  • If the tumor infiltrates to the submucosal layer, the surface of the membrane will be smooth and the nasopharynx will be depressed
  • Cranial nerve involvement is reflected by:
    Paralysis of the eyeball
    Facial hypothesia or hypoalgesia
    Difficulty opening the mouth
    Inclination of the tongue when it protrudes
    Aphasia
    Paralysis of the soft palate
    Disappearance of the gullet response
  • Fever and chills
  • Maybe fever only
  • Achiness
  • Anhidrosis
  • Headache
  • Cough
  • Asthma
  • Aversion to Cold
  • Edema
  • Thirst
  • Restlessness
  • Irritability
  • Fidgeting
  • Constipation
  • Sometimes dry achy eyes
  • T: Normal or red
  • C: Yellow or white
  • P: Floating and tight or rapid
Treatment Principle
  • Expel Wind
  • Disperse Cold
  • Cool Heat
Herb Formulas
  • Cocklebur Angelica Dahuricae Decoction
 Cocklebur   Disperses Wind, dispels Dampness and opens the nasal passages.
With Magonila flower, unblocks the nasal passages and treats headache and profuse nasal discharge.
Flos Magnoliae    

Expels Wind-Cold and unblocks the nasal passages.

This is the most essential herb in the treatment of nasal and sinus conditions, In addition, this is an excellent herb to use for external facial cream for chloasma.

Radix Angelicae Dahuricae     Releases the exterior, disperses Cold, opens the nasal orifices, disperses Wind-Dampness, alleviates pain and headache, reduces swelling and expels pus.
With Cocklebur and Magnoliae Flower, for headache due to nasal congestion with thick putrid discharge.
Herba Menthae  
Disperses Wind-Heat, clears the head and eyes and benefits the throat.

 

 

Directions:  First soak the herbal decoction in a gallon of water for 20 minutes. Next add the Magnoliae flower but place it in the  Muslin small bag, then boil for 17 minutes, leave the tea on and add the Mint and let it boil with the rest of the herbs for three minutes, afterward,  strain and drink one cup with each meal.

For Women: Drink a 2-3 cups daily a week before your scheduled cycle.

SAFETY

- Consult your herbalist or physician before use if you are taking other medications or receiving other medical treatments.

DISCLAIMER

Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.